SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending as the community discusses its potential, noting a recent price pump and increased trading volume. Some speculate about the catalyst behind the movement, while others point to cross-chain analysis indicating potential whale accumulation. Despite the positive price action, skepticism remains due to ICP's past performance and concerns about its tokenomics.

Grindr, Inc. engages in the operation of a social media network application for the gay, bi, trans, queer, and other members of the LGBTQ+ community. The company was founded in 2009 and is headquartered in West Hollywood, CA.

Grindr Inc - Ordinary Shares - Class A

Grindr Inc

Grindr is trending due to buyout speculation, with major shareholders proposing a take-private deal at $18 per share, creating significant community buzz around a potential near-term return. Discussions also involve the possibility of short squeezes given the stock's high short interest. Some traders are weighing in on whether minority shareholders will get a fair deal.

zkSync

ZK is trending as community members discuss its potential, particularly after the delivery of Atlas. Bullish sentiment seems to be building, with some eyeing key resistance levels and anticipating further upside for the project. Recent developments around ZK-tech, enterprise solutions, and compiler updates are also driving interest.

Peloton Interactive, Inc. provides an at-home fitness platform for live and on-demand indoor cycling classes. The firm pioneered connected, technology-enabled fitness, and the streaming of immersive, instructor-led boutique classes for its members. It operates through the Connected Fitness Products and Subscription segments. The Connected Fitness Products segment includes the sales of bikes, tread & related accessories. The Subscription segment refers to the monthly subscription and credits from live studio classes. The company was founded by John Foley, Graham Stanton, Thomas Cortese, Yony Feng, and Hisao Kushi in 2012 and is headquartered in New York, NY.

Peloton Interactive Inc - Ordinary Shares - Class A

Peloton Interactive Inc

Peloton is trending as analysts turn bullish following recent financial results and upgrades from Goldman Sachs and Macquarie, with community members discussing potential for a turnaround. Speculation includes possible AI integration and a potential short squeeze, with some comparing PTON's potential to Carvana's comeback. However, others remain skeptical, citing a challenging macroeconomic environment and past disappointments.

Optimism is more than just a single blockchain – it's a growing network of chains called the Superchain, all built on the open-source OP Stack. While OP Mainnet was the first, many prominent chains now run on the Optimism’s OP Stack, including Base (by Coinbase), Unichain (by Uniswap), Ink (by Kraken), and World Chain (by Worldcoin). The OP Stack has become the leading framework for Ethereum Layer 2 chains, powering the majority of L2 activity today. Every OP Chain in the Superchain contributes back to the Optimism Collectiv and all chains follow a standardized revenue-sharing model: the greater of 2.5% of total chain revenue or 15% of onchain profit (defined as fees minus L1 gas costs) is paid back to the Optimism. By aligning economic incentives across many chains, Optimism transforms Ethereum scaling into a sustainable flywheel by delivering fast, low-cost transactions while reinvesting in the future of the ecosystem. OP holders participate in governance to shape protocol upgrades, funding decisions, and more.

Optimism Coin

Optimism Coin is trending as investors discuss its potential as a major retail squeeze candidate, while some traders are shorting, anticipating a collapse following the FOMC meeting. Community members are actively debating whether altcoins are dead while also assessing the impact of news such as the NEAR Foundation partnership on price movements.

Sprott Physical Platinum and Palladium Trust - Unit

Sprott Physical Platinum & Palladium

SPPP is trending as precious metals and the materials sector gain momentum, with platinum and palladium potentially outperforming gold and silver. The community is closely watching for breakouts and discussing the potential for a commodity super cycle. Some investors believe SPPP represents a compelling opportunity, given the limited supply and increasing demand for platinum and palladium in catalytic converters and other industrial applications.

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

International Flavors & Fragrances Inc.

IFF is trending due to upcoming Q3 earnings report, with mixed expectations as solid segment performance faces potential margin squeeze from rising costs; analysts are weighing in with updated ratings and price targets. The community is actively discussing option strategies and potential ROI, with some seeing a longer-term value opportunity supported by a stable dividend and potential for operational efficiency. Recent news includes strategic partnerships, product launches, and insider activity.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

BHVN is trending as investors discuss its potential as a squeeze candidate and analyze options activity, particularly call buying. The community is focused on upcoming catalysts, including the FDA's PDUFA review for troriluzole in Q4 2025, with discussion around potential approval and market impact. Some traders are weighing the impact of a possible government shutdown on FDA timelines.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

TERN is trending as the community discusses its potential as a buyout candidate and strategic restructuring after a recent discontinuation of metabolic programs. Despite the setback in its obesity program, the stock price has seen improvement, leading to speculation about a potential acquisition or licensing deal. Investors are also monitoring upcoming trial data for its CML program as a key catalyst.

Listed Funds Trust - Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF

The Teucrium 2x Long Daily XRP ETF ($XXRP) is trending as traders discuss its potential for amplified gains relative to XRP, particularly with upcoming catalysts like potential regulatory clarity and spot ETF approvals. Community members are actively trading the ETF, with some citing substantial profits and accumulating shares during dips, while others express concerns about its tracking accuracy and decay over time. Speculation is also rising around potential price targets, trading strategies, and its long-term investment viability within the broader context of the crypto market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates

Dare Bioscience (DARE) delivered earnings and revenue surprises of +18.18% and -103.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Immatics (IMTX) Reports Q2 Loss, Misses Revenue Estimates

Immatics (IMTX) delivered earnings and revenue surprises of -73.68% and -62.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates

Editas (EDIT) delivered earnings and revenue surprises of -53.66% and +320.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates

C4 Therapeutics (CCCC) delivered earnings and revenue surprises of +2.63% and -0.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Arvinas, Inc. (ARVN) Reports Q2 Loss, Misses Revenue Estimates

Arvinas (ARVN) delivered earnings and revenue surprises of +3.45% and -53.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year?

Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates

Acadia Healthcare (ACHC) Beats Q1 Earnings Estimates

After a volatile week on Wall Street, investors are highly-anticipating earnings announcements from a mining firm, a biopharmaceutical company and video-sharing platform on Monday. Here’s a look at what to expect from their quarterly earnings and how retail investors are assessing these firms ahead of the results.1. Barrick Gold (GOLD): The gold-miner is expected to report earnings per share (EPS) of $0.28 and a revenue of $3.13 billion when it announces its second-quarter results on Monday before the bell. Recently, the firm had reported a 1% QoQ rise in its preliminary gold production for the quarter-ended June 2024 at 948,000 ounces. Preliminary sales for the quarter rose 5% to 956,000 ounces of gold.Barrick had indicated that gold and copper production in 2024 is expected to progressively increase each quarter with a higher weighting in the second half. Despite the positive outlook, retail sentiment on Stocktwits continues to trend in the ‘neutral’ zone (51/100) ahead of the earnings announcement.<figure class="image"><a href="https://stocktwits.com/symbol/GOLD"><img style="aspect-ratio:1526/440;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_08_09_at_8_32_36_AM_cdef87bd93.png" alt="Barrick Gold sentiment meter as of 7:08 a.m. EST on August 09, 2024" width="1526" height="440"></a><figcaption>Barrick Gold sentiment meter as of 7:08 a.m. EST on August 09, 2024</figcaption></figure>2. Dare Bioscience Inc (DARE): The clinical-stage biopharmaceutical company focused on women’s health is expected to report a second-quarter earnings loss of $0.66 when it announces its results after the market close on Monday.&nbsp;Investors will be watching whether the firm manages to improve its revenues during the quarter and for any guidance updates. Shares of the firm have lost over 17% since the beginning of the year.3. Rumble Inc (RUM): The video-sharing platform is expected to post an earnings loss of $0.15 and a revenue of $19.69 million when it announces its second-quarter results on Monday after the closing bell. The firm grabbed eyeballs this week after it joined the social media platform X to file antitrust lawsuits that alleged a conspiracy to withhold advertising revenue from Rumble and other digital media platforms.Rumble has named World Federation of Advertisers (WFA) as well as advertising agency WPP and its subsidiary GroupM Worldwide as defendants.Ahead of the earnings, retail sentiment on Stocktwits has flipped into the ‘bearish’ territory (31/100) from the ‘bullish’ zone a day ago.<figure class="image"><a href="https://stocktwits.com/symbol/RUM"><img style="aspect-ratio:1520/436;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_08_09_at_8_32_53_AM_62e07fc36b.png" alt="Rumble sentiment meter as of 7:35 EST on August 09, 2024" width="1520" height="436"></a><figcaption>Rumble sentiment meter as of 7:35 EST on August 09, 2024</figcaption></figure>

Barrick says gold and copper production in 2024 is expected to gradually increase each quarter. Photo via Vecteezy

Earnings Preview: Retail Investors Display Uncertainty And Bearishness For Barrick Gold And Rumble

Barrick Gold is expected to report earnings per share (EPS) of $0.28 and a revenue of $3.13 billion. Meanwhile, Rumble is expected to post an earnings loss of $0.15 and a revenue of $19.69 million.

Equity

Dare Bioscience files to sell 15M shares of common stock for holders

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley on November 28, 2005 and is headquartered in San Diego, CA.

Dare Bioscience Inc

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

DARE
Dare Bioscience Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DARE News

DAREDare Bioscience Inc